Literature DB >> 30035315

Multicomponent Interventions Reduce High-Risk Medications for Delirium in Hospitalized Older Adults.

Mobolaji Adeola1, Rejena Azad1, Gizat M Kassie2, Beverly Shirkey3, George Taffet4, Michael Liebl1, Kathryn Agarwal4,5.   

Abstract

Delirium threatens the functional independence and cognitive capacity of patients. Medications, especially those with strong anticholinergic effects, have been implicated as a preventable cause of delirium. We evaluated the effect of multicomponent interventions aimed at reducing the use of 9 target medications in hospitalized older adults at risk of delirium. This continuous quality improvement program was undertaken at a tertiary care facility and 4 community hospitals in a hospital system. We included 21, 541 hospital admissions with patients aged 70 and older on acute care medical or surgical units from the preintervention (2012) period, and 27,764 from the postintervention (2015) period. Implemented interventions include formulary and policy changes, technology-assisted medication review, age-conditional order set modifications, best practice alerts, and education. The proportion of hospital admissions with individual's receiving at least 1 target medication declined from 45.6% to 31.3% (relative reduction (RR)=31.4%) from before to after the intervention, meaning that target medication exposure was avoided in approximately 4,000 older adults. The greatest effect was observed for zolpidem (11.2% to 5.3%, RR=52.6%) and diphenhydramine (12.9% to 7.1%, RR=45%). Furthermore, the mean number of doses administered during all hospital admissions was reduced for 7 of 9 medications. Multicomponent interventions implemented in our hospital system were effective at reducing exposure to target medications in hospitalized older adults at risk of delirium. These systematic changes applied throughout the medication use process are sustained today.
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  delirium; hospitalization; potentially inappropriate medications; quality improvement

Mesh:

Substances:

Year:  2018        PMID: 30035315     DOI: 10.1111/jgs.15438

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  Hospitalizations of older people in an emergency department related to potential medication-induced hyperactive delirium: a cross-sectional study.

Authors:  Júlia Raso; Lincoln Marques Cavalcante Santos; Débora Alves Reis; Marília Amaral Costa Frangiotti; Ariane Cristina Barboza Zanetti; Helaine Carneiro Capucho; Maria Teresa Herdeiro; Fátima Roque; Leonardo Régis Leira Pereira; Fabiana Rossi Varallo
Journal:  Int J Clin Pharm       Date:  2022-01-27

2.  Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.

Authors:  Richard J Lin; Patrick D Hilden; Theresa A Elko; Parastoo B Dahi; Armin Shahrokni; Ann A Jakubowski; Miguel-Angel Perales; Craig S Sauter; Hugo R Castro-Malaspina; Juliet N Barker; Brian C Shaffer; Roni Tamari; Esperanza B Papadopoulos; Molly A Maloy; Beatriz Korc-Grodzicki; Sergio A Giralt
Journal:  Blood Adv       Date:  2019-01-08

3.  Policy parameters for optimising hospital ePrescribing: An exploratory literature review of selected countries of the Organisation for Economic Co-operation and Development.

Authors:  Uditha T Perera; Catherine Heeney; Aziz Sheikh
Journal:  Digit Health       Date:  2022-03-21

4.  Risk factors for delirium after surgery for craniocerebral injury in the neurosurgical intensive care unit.

Authors:  Ri-Yu Chen; Chang-Hui Zhong; Wei Chen; Ming Lin; Chang-Fu Feng; Chang-Neng Chen
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

5.  Impact of a delirium prevention project among older hospitalized patients who underwent orthopedic surgery: a retrospective cohort study.

Authors:  Jung-Yeon Choi; Kwang-Il Kim; Min-Gu Kang; Young-Kyun Lee; Kyung-Hoi Koo; Joo Han Oh; Young Ho Park; Jeewon Suh; Nak-Hyun Kim; Hyun-Jung Yoo; Jahyun Koo; Hyun Mi Moon; Eun Hui Kim; Kayoung Park; Cheol-Ho Kim
Journal:  BMC Geriatr       Date:  2019-10-26       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.